Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 97

    1.

    Public reporting of antibiotic timing in patients with pneumonia: lessons from a flawed performance measure.

    Wachter RM, Flanders SA, Fee C, Pronovost PJ.

    Ann Intern Med. 2008 Jul 1;149(1):29-32.PMID: 18591635 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    The unintended, negative consequences of the door-to-antibiotic measure for pneumonia.

    Srouji N.

    Ann Intern Med. 2009 Feb 3;150(3):220; author reply 220. No abstract available. PMID: 19189917 [PubMed - indexed for MEDLINE]Related articlesFree article

    3.

    The unintended, negative consequences of the door-to-antibiotic measure for pneumonia.

    Gogol M.

    Ann Intern Med. 2009 Feb 3;150(3):219; author reply 220. No abstract available. PMID: 19189914 [PubMed - indexed for MEDLINE]Related articlesFree article

    4.

    The unintended, negative consequences of the door-to-antibiotic measure for pneumonia.

    Dean NC.

    Ann Intern Med. 2009 Feb 3;150(3):219; author reply 220. No abstract available. PMID: 19189915 [PubMed - indexed for MEDLINE]Related articlesFree article

    5.

    Emergency department operational changes in response to pay-for-performance and antibiotic timing in pneumonia.

    Pines JM, Hollander JE, Lee H, Everett WW, Uscher-Pines L, Metlay JP.

    Acad Emerg Med. 2007 Jun;14(6):545-8. Epub 2007 Apr 30.PMID: 17470905 [PubMed - indexed for MEDLINE]Related articles

    6.

    What have we learned about how to measure quality of care for patients with community-acquired pneumonia?

    Metersky ML, Abend SL, Meehan TP.

    Respir Care Clin N Am. 2005 Mar;11(1):87-98. Review.PMID: 15763224 [PubMed - indexed for MEDLINE]Related articles

    7.

    Outpatient care compared with hospitalization for community-acquired pneumonia: a randomized trial in low-risk patients.

    Carratalà J, Fernández-Sabé N, Ortega L, Castellsagué X, Rosón B, Dorca J, Fernández-Agüera A, Verdaguer R, Martínez J, Manresa F, Gudiol F.

    Ann Intern Med. 2005 Feb 1;142(3):165-72.PMID: 15684204 [PubMed - indexed for MEDLINE]Related articlesFree article

    8.

    Timing of antibiotics for acute, severe infections.

    Pines JM.

    Emerg Med Clin North Am. 2008 May;26(2):245-57, vii. Review.PMID: 18406974 [PubMed - indexed for MEDLINE]Related articles

    9.

    Performance measurement in community-acquired pneumonia: consequences intended and unintended.

    File TM Jr, Gross PA.

    Clin Infect Dis. 2007 Apr 1;44(7):942-4. Epub 2007 Feb 20. No abstract available. PMID: 17342645 [PubMed - indexed for MEDLINE]Related articles

    10.

    When to switch therapy in patients with severe community-acquired pneumonia.

    Mortensen EM, Restrepo MI, Anzueto A.

    Ann Intern Med. 2008 Apr 15;148(8):625; author reply 625-6. No abstract available. PMID: 18413627 [PubMed - indexed for MEDLINE]Related articlesFree article

    12.

    Processes of care, illness severity, and outcomes in the management of community-acquired pneumonia at academic hospitals.

    Dedier J, Singer DE, Chang Y, Moore M, Atlas SJ.

    Arch Intern Med. 2001 Sep 24;161(17):2099-104.PMID: 11570938 [PubMed - indexed for MEDLINE]Related articlesFree article

    13.

    Tailored interventions to improve antibiotic use for lower respiratory tract infections in hospitals: a cluster-randomized, controlled trial.

    Schouten JA, Hulscher ME, Trap-Liefers J, Akkermans RP, Kullberg BJ, Grol RP, van der Meer JW.

    Clin Infect Dis. 2007 Apr 1;44(7):931-41. Epub 2007 Feb 20.PMID: 17342644 [PubMed - indexed for MEDLINE]Related articles

    14.

    Administration of first hospital antibiotics for community-acquired pneumonia: does timeliness affect outcomes?

    Houck PM, Bratzler DW.

    Curr Opin Infect Dis. 2005 Apr;18(2):151-6. Review.PMID: 15735420 [PubMed - indexed for MEDLINE]Related articles

    15.

    The community-acquired pneumonia symptom questionnaire: a new, patient-based outcome measure to evaluate symptoms in patients with community-acquired pneumonia.

    Lamping DL, Schroter S, Marquis P, Marrel A, Duprat-Lomon I, Sagnier PP.

    Chest. 2002 Sep;122(3):920-9.PMID: 12226033 [PubMed - indexed for MEDLINE]Related articlesFree article

    16.

    Pay for performance for antibiotic timing in pneumonia: caveat emptor.

    Pines JM, Hollander JE, Datner EM, Metlay JP.

    Jt Comm J Qual Patient Saf. 2006 Sep;32(9):531-5.PMID: 17987877 [PubMed - indexed for MEDLINE]Related articles

    17.

    Understanding variation in quality of antibiotic use for community-acquired pneumonia: effect of patient, professional and hospital factors.

    Schouten JA, Hulscher ME, Kullberg BJ, Cox A, Gyssens IC, van der Meer JW, Grol RP.

    J Antimicrob Chemother. 2005 Sep;56(3):575-82. Epub 2005 Jul 27.PMID: 16049096 [PubMed - indexed for MEDLINE]Related articlesFree article

    18.

    Long-term symptom recovery and health-related quality of life in patients with mild-to-moderate-severe community-acquired pneumonia.

    El Moussaoui R, Opmeer BC, de Borgie CA, Nieuwkerk P, Bossuyt PM, Speelman P, Prins JM.

    Chest. 2006 Oct;130(4):1165-72.PMID: 17035452 [PubMed - indexed for MEDLINE]Related articlesFree article

    19.
    20.

    Long-term outcome and quality of care of patients with Staphylococcus aureus bacteremia.

    Fätkenheuer G, Preuss M, Salzberger B, Schmeisser N, Cornely OA, Wisplinghoff H, Seifert H.

    Eur J Clin Microbiol Infect Dis. 2004 Mar;23(3):157-62. Epub 2004 Feb 25.PMID: 14986158 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Find related data